NeoGenomics, Inc. Interest Income (Expense), Net
NeoGenomics, Inc. (NEO) reported Interest Income (Expense), Net of $1.47 million for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-09.
Discontinued › Income Statement › Other Income
us-gaap:InterestIncomeExpenseNet · last filed 2023-05-09
- NeoGenomics, Inc. interest income (expense), net for the quarter ending 2023-03-31 was $1.47M.
- NeoGenomics, Inc. interest income (expense), net for the quarter ending 2022-03-31 was -$1.30M.
- NeoGenomics, Inc. interest income (expense), net for the quarter ending 2018-09-30 was -$1.87M.
- NeoGenomics, Inc. interest income (expense), net for the quarter ending 2018-06-30 was -$1.41M.
- NeoGenomics, Inc. interest income (expense), net for fiscal 2017 was $5.54M, a 44.59% decline from fiscal 2016.
- NeoGenomics, Inc. interest income (expense), net for fiscal 2016 was $10.00M.
| Period end | Interest Income (Expense), Net 3 month | Interest Income (Expense), Net 3 month as first filed | Interest Income (Expense), Net 6 month | Interest Income (Expense), Net 9 month | Interest Income (Expense), Net 12 month |
|---|---|---|---|---|---|
| 2023-03-31 | $1.47M 10-Q · filed 2023-05-09 | ||||
| 2022-03-31 | -$1.30M 10-Q · filed 2023-05-09 | ||||
| 2018-09-30 | -$1.87M 10-Q · filed 2018-11-06 | -$3.28M derived: sum of 2 quarters · filed 2018-11-06 | -$4.77M 10-Q · filed 2018-11-06 | $4.95M derived: sum of 4 quarters · filed 2019-02-26 | |
| 2018-06-30 | -$1.41M 10-Q · filed 2018-08-06 | -$2.89M 10-Q · filed 2018-08-06 | $6.82M derived: sum of 3 quarters · filed 2019-02-26 | $5.42M derived: sum of 4 quarters · filed 2019-02-26 | |
| 2018-03-31 | -$1.49M 10-Q · filed 2018-05-08 | $8.23M derived: sum of 2 quarters · filed 2019-02-26 | $6.83M derived: sum of 3 quarters · filed 2019-02-26 | $5.42M derived: sum of 4 quarters · filed 2019-02-26 | |
| 2017-12-31 | $9.71M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $8.31M derived: sum of 2 quarters · filed 2019-02-26 | $6.90M derived: sum of 3 quarters · filed 2019-02-26 | $5.54M 10-K · filed 2019-02-26 | |
| 2017-09-30 | -$1.40M 10-Q · filed 2018-11-06 | -$2.81M derived: sum of 2 quarters · filed 2018-11-06 | -$4.17M 10-Q · filed 2018-11-06 | $10.33M derived: sum of 4 quarters · filed 2019-02-26 | |
| 2017-06-30 | -$1.41M 10-Q · filed 2018-08-06 | -$2.77M 10-Q · filed 2018-08-06 | $11.73M derived: sum of 3 quarters · filed 2019-02-26 | $10.26M derived: sum of 4 quarters · filed 2019-02-26 | |
| 2017-03-31 | -$1.36M 10-Q · filed 2018-05-08 | $13.14M derived: sum of 2 quarters · filed 2019-02-26 | $11.68M derived: sum of 3 quarters · filed 2019-02-26 | $10.23M derived: sum of 4 quarters · filed 2019-02-26 | |
| 2016-12-31 | $14.51M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $13.04M derived: sum of 2 quarters · filed 2019-02-26 | $11.59M derived: sum of 3 quarters · filed 2019-02-26 | $10.00M 10-K · filed 2019-02-26 | |
| 2016-09-30 | -$1.47M 10-Q · filed 2017-11-13 | -$2.92M derived: sum of 2 quarters · filed 2017-11-13 | -$4.51M 10-Q · filed 2017-11-13 | ||
| 2016-06-30 | -$1.45M 10-Q · filed 2017-08-07 | -$3.04M 10-Q · filed 2017-08-07 | |||
| 2016-03-31 | -$1.59M 10-Q · filed 2017-05-09 | $1.59M 10-Q · filed 2016-05-10 | |||
| 2015-09-30 | -$239.00K 10-Q · filed 2016-11-07 | -$428.00K derived: sum of 2 quarters · filed 2016-11-07 | -$623.00K 10-Q · filed 2016-11-07 | ||
| 2015-06-30 | -$189.00K 10-Q · filed 2016-08-05 | -$384.00K 10-Q · filed 2016-08-05 | |||
| 2015-03-31 | $195.00K 10-Q · filed 2016-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |